Fineline Cube

Follow:
14435 Articles
AIM Vaccine Leverages DeepSeek AI to Optimize mRNA Shingles Vaccine Design
CompanyDrug

AIM Vaccine Leverages DeepSeek AI to Optimize mRNA Shingles Vaccine Design

Innovent Biologics' Ipilimumab NDA Accepted by CDE with Priority Review for Colon Cancer
CompanyDrug

Innovent Biologics’ Ipilimumab NDA Accepted by CDE with Priority Review for Colon Cancer

AI in Healthcare: The Impact of DeepSeek Technology and Industry Developments
Policy / Regulatory

AI in Healthcare: The Impact of DeepSeek Technology and Industry Developments

In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications
Policy / Regulatory

In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications

State Council's Draft Plan Boosts Innovative Drug Development via Medical Insurance Reforms
Policy / Regulatory

State Council’s Draft Plan Boosts Innovative Drug Development via Medical Insurance Reforms

Roche Unveils Sequencing by Expansion (SBX) Technology for Next-Generation Sequencing
CompanyMedical Device

Roche Unveils Sequencing by Expansion (SBX) Technology for Next-Generation Sequencing

Shanghai Issues Legal Guidebook for Innovative Drug Marketing
Policy / Regulatory

Shanghai Issues Legal Guidebook for Innovative Drug Marketing

China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation
Policy / Regulatory

China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation

Roche's Tecentriq Wins Japan Approval for Alveolar Soft Part Sarcoma
CompanyDrug

Roche’s Tecentriq Wins Japan Approval for Alveolar Soft Part Sarcoma

GSK's Nucala Receives NMPA Review for COPD Treatment
CompanyDrug

GSK’s Nucala Receives NMPA Review for COPD Treatment

Nuwacell Biotech’s NCR101 Approved for ILD Clinical Study by China’s CDE
CompanyDrug

Nuwacell Biotech’s NCR101 Approved for ILD Clinical Study by China’s CDE

Baxter International Reports Q4 2024 Revenues of USD 2.75B, Up 2% YOY
Company

Baxter International Reports Q4 2024 Revenues of USD 2.75B, Up 2% YOY